Interleukin 1 polymorphisms in patients with ankylosing spondylitis in Korea

Journal of Rheumatology

Volumn 35, Issue 8, 2008, Pages 1603-1608

  Kim, Tae Jong ^a   Kim, Tae Hwan ^b,f   Lee, Hyun Joo ^b   Peddle, Lynette ^c   Rahman, Proton ^c   Hu, Pingzhao ^d   Greenwood, Celia M T ^d   Inman, Robert D ^e  

^a Chonnam National University Medical School   (South Korea)

^b Hanyang University College of Medicine   (South Korea)

^c MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^d HOSPITAL FOR SICK CHILDREN   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

^f Hanyang University Medical Center   (South Korea)

Author keywords

Ankylosing spondylitis; Interleukin 1; Korea; Polymorphisms

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA;

ADULT; ANKYLOSING SPONDYLITIS; ARTICLE; CONTROLLED STUDY; FEMALE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; HAPLOTYPE; HUMAN; HUMAN TISSUE; KOREA; MAJOR CLINICAL STUDY; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; INTERLEUKIN-1; KOREA; MALE; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; SPONDYLITIS, ANKYLOSING;

EID: 49049089132     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Braun J, Bollow M, Remlinger G, et al. Prevalence of spondylarthropathies in HLA-B27 positive and negative blood donors. Arthritis Rheum 1998;41:58-67.
2. van der Linden S, Valkenburg H, Cats A. The risk of developing ankylosing spondylitis in HLA-B27 positive individuals: a family and population study. Br J Rheumatol 1983;22:18-9.
3. Brown MA, Kennedy LG, MacGregor AJ, et al. Susceptibility to ankylosing spondylitis in twins: the role of genes, HLA, and the environment. Arthritis Rheum 1997;40:1823-8.
4. Brewerton DA, Hart FD, Nicholls A, Caffrey M, James DC, Sturrock RD. Ankylosing spondylitis and HLA-27. Lancet 1973;1:904-7.
5. Laval SH, Timms A, Edwards S, et al. Whole-genome screening in ankylosing spondylitis: evidence of non-MHC genetic-susceptibility loci. Am J Hum Genet 2001;68:918-26.
6. Nicklin MJ, Weith A, Duff GW. A physical map of the region encompassing the human interleukin-1 alpha, interleukin-1 beta, and interleukin-1 receptor antagonist genes. Genomics 1994;19:382-4.
7. McGarry F, Neilly J, Anderson N, Sturrock R, Field M. A polymorphism within the interleukin 1 receptor antagonist (IL-1Ra) gene is associated with ankylosing spondylitis. Rheumatology Oxford 2001;40:1359-64.
8. Timms AE, Crane AM, Sims AM, et al. The interleukin 1 gene cluster contains a major susceptibility locus for ankylosing spondylitis. Am J Hum Genet 2004;75:587-95.
9. van der Paardt M, Crusius JB, Garcia-Gonzalez MA, et al. Interleukin-1-beta and interleukin-1 receptor antagonist gene polymorphisms in ankylosing spondylitis. Rheumatology Oxford 2002;41:1419-23.
10. Maksymowych WP, Reeve JP, Reveille JD, et al. High-throughput single-nucleotide polymorphism analysis of the IL1RN locus in patients with ankylosing spondylitis by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Arthritis Rheum 2003;48:2011-8.
11. Chou CT, Timms AE, Wei JC, Tsai WC, Wordsworth BP, Brown MA. Replication of association of ILl gene complex members with ankylosing spondylitis in Taiwanese Chinese. Ann Rheum Dis 2006;65:1106-9.
12. Maksymowych WP, Rahman P, Reeve JP, Gladman DD, Peddle L, Inman RD. Association of the IL1 gene cluster with susceptibility to ankylosing spondylitis: an analysis of three Canadian populations. Arthritis Rheum 2006;54:974-85.
13. Rahman P, Sun S, Peddle L, et al. Association between the interleukin-1 family gene cluster and psoriatic arthritis. Arthritis Rheum 2006;54:2321-5.
14. Kim TH, Stone MA, Rahman P, et al. Interleukin 1 and nuclear factor-kB polymorphisms in ankylosing spondylitis in Canada and Korea. J Rheumatol 2005;32:1907-10.
15. van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 1984;27:361-8.
16. Sasieni PD. From genotypes to genes: doubling the sample size. Biometrics 1997;53:1253-61.
17. Aulchenko YS, Ripke S, Isaacs A, van Duijn CM. GenABEL: an R library for genome-wide association analysis. Bioinformatics 2007;23:1294-6.
18. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005;21:263-5.
19. Schaid DJ, Rowland CM, Tines DE, Jacobson RM, Poland GA. Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet 2002;70:425-34.
20. Danis VA, Millington M, Hyland VJ, Grennan D. Cytokine production by normal human monocytes: inter-subject variation and relationship to an IL-1 receptor antagonist (IL-1Ra) gene polymorphism. Clin Exp Immunol 1995;99:303-10.
21. Jin L, Zhang G, Akey JM, et al. Lack of linkage of IL1RN genotypes with ankylosing spondylitis susceptibility. Arthritis Rheum 2004;50:3047-8.
22. Mattuzzi S, Barbi S, Carletto A, et al. Association of polymorphisms in the IL1B and IL2 genes with susceptibility and severity of systemic sclerosis. J Rheumatol 2007;34:997-1004.
23. Camargo MC, Mera R, Correa P, et al. Interleukin-1β and interleukin-1 receptor antagonist gene polymorphisms and gastric cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2006;15:1674-87.
24. Shirts BH, Wood J, Yolken RH, Nimgaonkar VL. Association study of IL10, IL1-beta, and IL1RN and schizophrenia using tag SNPs from a comprehensive database: suggestive association with rs16944 at IL1-beta. Schizophr Res 2006;88:235-44.
25. Kang S, Kim JW, Park NH, et al. Interleukin-1 beta-511 polymorphism and risk of cervical cancer. J Korean Med Sci 2007;22:110-3.
26. Lee SH, Ihm CG, Sohn SD, et al. Polymorphisms in interleukin-1 beta and interleukin-1 receptor antagonist genes are associated with kidney failure in Korean patients with type 2 diabetes mellitus. Am J Nephrol 2004;24:410-4.
27. Freimer NB, Sabatti C. Guidelines for association studies in Human Molecular Genetics. Hum Mol Genet 2005;14:2481-3.
28. Gauderman WJ, Morrison JM. Quanto 1.1: A computer program for power and sample size calculations for genetic-epidemiology studies. Internet. Available from: http://hydra.usc.edu/gxe. Accessed April 2, 2008.
29. Gauderman WJ. Sample size requirements for matched case-control studies of gene-environment interaction. Stat Med 2002;21:35-50.